Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Autor: Kathleen M Mullane, Vicki A Morrison, Luis H Camacho, Ann Arvin, Shelly A McNeil, Jessie Durrand, Bernadette Campbell, Shu-Chih Su, Ivan S F Chan, Janie Parrino, Susan S Kaplan, Zoran Popmihajlov, Paula W Annunziato, S Cerana, MO Dictar, P Bonvehi, JP Tregnaghi, L Fein, D Ashley, M Singh, T Hayes, G Playford, O Morrissey, J Thaler, T Kuehr, R Greil, M Pecherstorfer, L Duck, K Van Eygen, M Aoun, B De Prijck, FA Franke, CHE Barrios, AVA Mendes, SV Serrano, RF Garcia, F Moore, JFC Camargo, LA Pires, RS Alves, A Radinov, K Oreshkov, V Minchev, AI Hubenova, T Koynova, I Ivanov, B Rabotilova, PA Petrov, P Chilingirov, S Karanikolov, J Raynov, D Grimard, S McNeil, D Kumar, LM Larratt, K Weiss, R Delage, FJ Diaz-Mitoma, PO Cano, F Couture, P Carvajal, A Yepes, R Torres Ulloa, P Fardella, C Caglevic, C Rojas, E Orellana, P Gonzalez, A Acevedo, KM Galvez, ME Gonzalez, S Franco, JG Restrepo, CA Rojas, C Bonilla, LE Florez, AV Ospina, R Manneh, R Zorica, DV Vrdoljak, M Samarzija, L Petruzelka, J Vydra, J Mayer, D Cibula, J Prausova, G Paulson, M Ontaneda, K Palk, A Vahlberg, R Rooneem, F Galtier, D Postil, F Lucht, F Laine, O Launay, H Laurichesse, X Duval, OA Cornely, B Camerer, J Panse, M Zaiss, H-G Derigs, H Menzel, M Verbeek, V Georgoulias, D Mavroudis, A Anagnostopoulos, E Terpos, D Cortes, J Umanzor, S Bejarano, RW Galeano, RSM Wong, P Hui, P Pedrazzoli, L Ruggeri, F Aversa, A Bosi, G Gentile, A Rambaldi, A Contu, L Marei, A Abbadi, W Hayajneh, J Kattan, F Farhat, G Chahine, J Rutkauskiene, LJ Marfil Rivera, YA Lopez Chuken, H Franco Villarreal, J Lopez Hernandez, H Blacklock, RI Lopez, R Alvarez, AM Gomez, TS Quintana, MDC Moreno Larrea, SJ Zorrilla, E Alarcon, FCA Samanez, PB Caguioa, BJ Tiangco, EM Mora, RD Betancourt-Garcia, D Hallman-Navarro, LJ Feliciano-Lopez, HA Velez-Cortes, F Cabanillas, DE Ganea, TE Ciuleanu, DG Ghizdavescu, L Miron, CL Cebotaru, CI Cainap, R Anghel, MV Dvorkin, OA Gladkov, NV Fadeeva, AA Kuzmin, ON Lipatov, II Zbarskaya, FS Akhmetzyanov, IV Litvinov, BV Afanasyev, M Cherenkova, D Lioznov, IA Lisukov, YA Smirnova, S Kolomietz, H Halawani, YT Goh, L Drgona, J Chudej, M Matejkova, M Reckova, BL Rapoport, WM Szpak, DR Malan, N Jonas, CW Jung, DG Lee, SS Yoon, J Lopez Jimenez, I Duran Martinez, JF Rodriguez Moreno, C Solano Vercet, R de la Camara, M Batlle Massana, S-P Yeh, C-Y Chen, H-H Chou, C-M Tsai, C-H Chiu, N Siritanaratkul, L Norasetthada, V Sriuranpong, K Seetalarom, H Akan, F Dane, MA Ozcan, GH Ozsan, SF Kalayoglu Besisik, A Cagatay, S Yalcin, A Peniket, SR Mullan, KM Dakhil, K Sivarajan, JJ-G Suh, A Sehgal, F Marquez, EG Gomez, MR Mullane, WL Skinner, RJ Behrens, DR Trevarthe, MA Mazurczak, EA Lambiase, CA Vidal, SY Anac, GA Rodrigues, B Baltz, R Boccia, MS Wertheim, CS Holladay, D Zenk, W Fusselman, JL Wade III, AJ Jaslowsk, J Keegan, MO Robinson, RS Go, J Farnen, B Amin, D Jurgens, GF Risi, PG Beatty, T Naqvi, S Parshad, VL Hansen, M Ahmed, PD Steen, S Badarinath, A Dekker, MA Scouros, DE Young, W Graydon Harker, SD Kendall, ML Citron, S Chedid, JG Posada, MK Gupta, S Rafiyath, J Buechler-Price, S Sreenivasappa, CH Chay, JM Burke, SE Young, A Mahmood, JW Kugler, G Gerstner, J Fuloria, ND Belman, R Geller, J Nieva, BP Whittenberger, BMY Wong, TP Cescon, G Abesada-Terk, MJ Guarino, A Zweibach, EN Ibrahim, G Takahashi, MA Garrison, RB Mowat, BS Choi, IA Oliff, J Singh, KA Guter, K Ayrons, KM Rowland, SJ Noga, SB Rao, A Columbie, MT Nualart, GR Cecchi, LT Campos, M Mohebtash, MR Flores, R Rothstein-Rubin, BM O'Connor, G Soori, M Knapp, FG Miranda, BW Goodgame, M Kassem, R Belani, S Sharma, T Ortiz, HL Sonneborn, AB Markowitz, D Wilbur, E Meiri, VS Koo, HS Jhangiani, L Wong, S Sanani, SJ Lawrence, CM Jones, C Murray, C Papageorgiou, JS Gurtler, JL Ascensao, ML Venigalla, M D'Andrea, C De Las Casas, DJ Haile, FU Qazi, JL Santander, MR Thomas, VP Rao, M Craig, RJ Garg, R Robles, RM Lyons, RK Stegemoller, S Goel, S Garg, P Lowry, C Lynch, B Lash, T Repka, J Baker, BS Goueli, TC Campbell, DA Van Echo, YJ Lee, EA Reyes, FM Senecal, G Donnelly, P Byeff, R Weiss, T Reid, E Roeland, A Goel, DM Prow, DS Brandt, HG Kaplan, JE Payne, MG Boeckh, PJ Rosen, RR Mena, R Khan, RF Betts, SA Sharp, VA Morrison, D Fitz-Patrick, J Congdon, N Erickson, R Abbasi, S Henderson, A Mehdi, EJ Wos, E Rehmus, L Beltzer, RA Tamayo, T Mahmood, AC Reboli, A Moore, JM Brown, J Cruz, DP Quick, JL Potz, KW Kotz, M Hutchins, NM Chowhan, YD Devabhaktuni, P Braly, RA Berenguer, SC Shambaugh, TJ O'Rourke, WA Conkright, CF Winkler, FEK Addo, JP Duic, KP High, ME Kutner, R Collins, DR Carrizosa, DJ Perry, E Kailath, N Rosen, R Sotolongo, S Shoham, T Chen

Summary Background Patients who are immunocompromised because of malignancy have an increased risk of herpes zoster and herpes zoster-related complications. We aimed to investigate the efficacy and safety of an inactivated varicella zoster virus (VZV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9512b960de076ec44f04d635a16f9143
http://hdl.handle.net/11573/1331005

Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.

Autor: Powell SF; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Dib EG; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Bleeker JS; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Keppen MD; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Mazurczak M; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Hack KM; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Gitau MM; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Steen PD; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Terstriep SA; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Reynolds J; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Landsverk ML; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Chan CH; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Nelson ME; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Thompson PA; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Ellison C; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Black LJ; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Ford JM; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Chung JH; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Anhorn R; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA., Gaba AG; Steven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Megan L. Landsverk, and Chun-Hung Chan, Sanford Cancer Center; Morgan E. Nelson, Paul A. Thompson, Christie Ellison, and Lora J. Black, Sanford Research, Sioux Falls, SD; Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, and Anu G. Gaba, Roger Maris Cancer Center, Fargo; John Reynolds, Sanford Cancer Center, Bismarck, ND; James M. Ford, Stanford University School of Medicine, Stanford, CA; Jon H. Chung and Rachel Anhorn, Foundation Medicine, Cambridge, MA.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2018 Nov; Vol. 2, pp. 1-12.

Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.

Autor: Neal JW; Stanford Cancer Institute, Stanford, CA, USA. Electronic address: jwneal@stanford.edu., Dahlberg SE; Dana Farber Cancer Institute, Boston, MA, USA., Wakelee HA; Stanford Cancer Institute, Stanford, CA, USA., Aisner SC; Rutgers Cancer Institute of New Jersey, Newark, NJ, USA., Bowden M; Dana Farber Cancer Institute, Boston, MA, USA., Huang Y; Dana Farber Cancer Institute, Boston, MA, USA., Carbone DP; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Gerstner GJ; Illinois CancerCare-Peoria, Peoria, IL, USA., Lerner RE; Park Nicollet Clinic, Saint Louis Park, MN, USA., Rubin JL; Community Hospital of the Monterey Peninsula, Monterey, CA, USA., Owonikoko TK; The Winship Cancer Institute of Emory University, Atlanta, GA, USA., Stella PJ; Saint Joseph Mercy Hospital, Ann Arbor, MI, USA., Steen PD; Roger Maris Cancer Center, Fargo, ND, USA., Khalid AA; Charleston Area Medical Center, Charleston, WV, USA., Ramalingam SS; The Winship Cancer Institute of Emory University, Atlanta, GA, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2016 Dec; Vol. 17 (12), pp. 1661-1671. Date of Electronic Publication: 2016 Nov 04.

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621.

Autor: Molina JR; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. Electronic address: molina.julian@mayo.edu., Foster NR; Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States., Reungwetwattana T; Division of Medical Oncology, Department of Internal Medicine, Ramathibodi Hospital, Bangkok, Thailand., Nelson GD; Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States., Grainger AV; Columbus Oncology & Hematology, Inc., 810 Jasonway Avenue, Suite A, Columbus, OH 43214l, United States., Steen PD; MeritCare Hospital CCOP, 820 4(th) Street North, Fargo, ND 58102, United States., Stella PJ; St. Joseph Mercy Cancer Center, 5301 McAuley Drive, Suite C-139, Ypsilanti, MI 48197, United States., Marks R; Division of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States., Wright J; CTEP Program, National Cancer Institute, Executive Plaza North, Suite 7115A, Rockville, MD 20852-7426, United States., Adjei AA; Roswell Park Cancer Institute, Elm and Carlton Street, Buffalo, NY 14263, United States.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2014 Aug; Vol. 85 (2), pp. 245-50. Date of Electronic Publication: 2014 May 01.

Hepatic arterial infusion and systemic chemotherapy after multiple metastasectomy in patients with colorectal carcinoma metastatic to the liver: a North Central Cancer Treatment Group (NCCTG) phase II study, 92-46-52.

Autor: Bolton JS; Ochsner Community Clinical Oncology Program, New Orleans, LA, USA., O'Connell MJ, Mahoney MR, Farr GH Jr, Fitch TR, Maples WJ, Nagorney DM, Rubin J, Fuloria J, Steen PD, Alberts SR

Publikováno v: Clinical colorectal cancer [Clin Colorectal Cancer] 2012 Mar; Vol. 11 (1), pp. 31-7. Date of Electronic Publication: 2011 May 13.